March 11th 2025, 9:00pm
Kelly Grosklags discusses how oncologists can guide patients in shared decision-making while managing expectations following a breast cancer diagnosis.
March 10th 2025, 4:00pm
Dr. Sara M. Tolaney discusses breast practices associated with CDK4/6 inhibitors for the treatment of breast cancer.
March 21st 2024, 1:00pm
A new robot-assisted nipple-conserving mastectomy is “not very different” in terms of patient experiences versus the traditional procedure.
March 20th 2024, 9:00pm
During the CURE Educated Patient® Breast Cancer Summit, an expert discussed her professional and personal experience with side effect management in metastatic breast cancer.
March 19th 2024, 1:00pm
ctDNA and CTC can lend information about early-stage breast cancer, but the best way to use this data is still being determined, an expert said at the CURE® Educated Patient® Breast Cancer Summit.
March 18th 2024, 9:00pm
Recent recommendations — which were discussed at the CURE® Educated Patient® Breast Cancer Summit — addressed changes in both genetic and genomic testing in breast cancer.
March 17th 2024, 5:00pm
A patient advocate and oncology nurse discuss the importance of physical and mental health during the breast cancer journey during a panel session at the CURE® Educated Patient® Breast Cancer Summit.
March 16th 2024, 5:00pm
During the Miami Breast Cancer Conference and Educated Patient® Breast Cancer Summit, one expert stressed the importance of genetic testing for BRCA mutations.
March 14th 2024, 3:00pm
A patient with breast cancer shares skills she’s learned from the Look Good Feel Better program at the Miami Breast Cancer Conference and Educated Patient® Breast Cancer Summit.
March 13th 2024, 7:00pm
While CDK4/6 inhibitors are “liberating” for this breast cancer subset, questions remain about what to do in later lines of therapy, according to a presentation at the CURE® Educated Patient Breast Cancer Summit.
Should I Quit My Day Job While Living With Cancer?
How Q-TWiST Can Guide Kidney Cancer Treatment Choices
Metastasis-Directed Radiotherapy Shows Improved Kidney Cancer Outcomes
Zusduri Shows Durable Responses in Some Bladder Cancers